Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity
- PMID: 32150314
- DOI: 10.1002/ejhf.1788
Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity
Abstract
Aims: Patient-reported quality of life (QOL) is a highly prognostic and clinically relevant endpoint in patients with heart failure (HF) with preserved ejection fraction (HFpEF). The relationships between QOL and different markers of HF severity remain unclear, particularly as they relate to functional capacity and directly measured activity levels. We hypothesized that QOL would demonstrate a stronger relationship with measures of exercise capacity and adiposity compared to other disease measures.
Methods and results: This is a secondary analysis of the National Heart, Lung, and Blood Institute-sponsored RELAX, NEAT-HFpEF and INDIE-HFpEF trials to determine the relationships between QOL (assessed by the Kansas City Cardiomyopathy Questionnaire and Minnesota Living with Heart Failure Questionnaire) and different domains reflecting HF severity, including maximal aerobic capacity (peak oxygen consumption), submaximal exercise capacity (6-min walk distance), volume of daily activity (accelerometry), physician-estimated functional class, resting echocardiography, and plasma natriuretic peptide levels. A total of 408 unique patients with chronic HFpEF were split into tertiles of QOL scores defined as QOLworst, QOLintermediate , QOLbest . The QOLworst HFpEF group was youngest, with a higher body mass index, greater prevalence of class II obesity and diabetes, and the lowest N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. After adjustment for age, sex and body mass index, poorer QOL was associated with worse physical capacity and activity levels, assessed by peak oxygen consumption, 6-min walk distance and actigraphy, but was not associated with NT-proBNP or indices from resting echocardiography. QOL was similarly reduced in patients with and without prior HF hospitalization.
Conclusions: Quality of life in HFpEF is poorest in patients who are young, obese and have diabetes, and is more robustly tied to measures reflecting functional capacity and daily activity levels rather than elevations in NT-proBNP or prior HF hospitalization. These findings have major implications for the understanding of QOL in HFpEF and for the design of future clinical trials targeting symptom improvement in HFpEF.
Clinical trial registration: RELAX, NCT00763867; NEAT-HFpEF, NCT02053493; INDIE-HFpEF, NCT02742129.
Keywords: Heart failure; Heart failure with preserved ejection fraction; Obesity; Quality of life.
© 2020 European Society of Cardiology.
Comment in
-
Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life.Eur J Heart Fail. 2020 Jun;22(6):1019-1021. doi: 10.1002/ejhf.1762. Epub 2020 Mar 10. Eur J Heart Fail. 2020. PMID: 32154649 No abstract available.
Similar articles
-
Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction.JACC Heart Fail. 2023 Nov;11(11):1549-1561. doi: 10.1016/j.jchf.2023.06.031. Epub 2023 Aug 9. JACC Heart Fail. 2023. PMID: 37565977 Free PMC article.
-
Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.Circ Heart Fail. 2017 Jun;10(6):e003878. doi: 10.1161/CIRCHEARTFAILURE.117.003878. Circ Heart Fail. 2017. PMID: 28588021 Free PMC article. Clinical Trial.
-
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.JAMA. 2018 Nov 6;320(17):1764-1773. doi: 10.1001/jama.2018.14852. JAMA. 2018. PMID: 30398602 Free PMC article. Clinical Trial.
-
The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Heart Lung Circ. 2024 Feb;33(2):197-208. doi: 10.1016/j.hlc.2023.11.022. Epub 2024 Feb 6. Heart Lung Circ. 2024. PMID: 38320881 Review.
-
Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.Heart Vessels. 2019 Apr;34(4):597-606. doi: 10.1007/s00380-018-1279-1. Epub 2018 Oct 12. Heart Vessels. 2019. PMID: 30315496 Review.
Cited by
-
A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction.Circ Heart Fail. 2023 Feb;16(2):e010161. doi: 10.1161/CIRCHEARTFAILURE.122.010161. Epub 2022 Oct 31. Circ Heart Fail. 2023. PMID: 36314122 Free PMC article. Clinical Trial.
-
Quality of Life in Patients with Coronary Artery Disease-Multicenter POLASPIRE II Study.J Clin Med. 2024 Jun 21;13(13):3630. doi: 10.3390/jcm13133630. J Clin Med. 2024. PMID: 38999196 Free PMC article.
-
Heart failure: an update from the last years and a look at the near future.ESC Heart Fail. 2022 Dec;9(6):3667-3693. doi: 10.1002/ehf2.14257. ESC Heart Fail. 2022. PMID: 36546712 Free PMC article. Review.
-
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets.Cardiovasc Res. 2023 Feb 3;118(18):3434-3450. doi: 10.1093/cvr/cvac120. Cardiovasc Res. 2023. PMID: 35880317 Free PMC article. Review.
-
Diastolic Filling Time, Chronotropic Response, and Exercise Capacity in Heart Failure and Preserved Ejection Fraction With Sinus Rhythm.J Am Heart Assoc. 2022 Jul 5;11(13):e026009. doi: 10.1161/JAHA.121.026009. Epub 2022 Jun 29. J Am Heart Assoc. 2022. PMID: 35766289 Free PMC article.
References
-
- Basch E. Patient-reported outcomes - harnessing patients' voices to improve clinical care. N Engl J Med 2017;376:105-108.
-
- Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV, Jones PG, Spertus JA. Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials. JAMA Cardiol 2017;2:1315-1321.
-
- Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, Davila-Roman VG, Mann DL, Spertus JA. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail 2013;6:1139-1146.
-
- Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-1255.
-
- Hamo CE, Heitner JF, Pfeffer MA, Kim HY, Kenwood CT, Assmann SF, Solomon SD, Boineau R, Fleg JL, Spertus JA, Lewis EF. Baseline distribution of participants with depression and impaired quality of life in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial. Circ Heart Fail 2015;8:268-277.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous